InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Jun 26, 2026, 4:00 PM EDT
1.010
-0.030 (-2.88%)
After-hours: Jun 26, 2026, 6:26 PM EDT
InterCure Employees
InterCure had 285 employees as of December 31, 2025. The number of employees decreased by 35 or -10.94% compared to the previous year.
Employees
285
Change (1Y)
-35
Growth (1Y)
-10.94%
Revenue / Employee
$297,387
Profits / Employee
-$39,303
Market Cap
57.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 285 | -35 | -10.94% |
| Dec 31, 2024 | 320 | 50 | 18.52% |
| Dec 31, 2023 | 270 | -100 | -27.03% |
| Dec 31, 2022 | 370 | 20 | 5.71% |
| Dec 31, 2021 | 350 | 275 | 366.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zhengye Biotechnology Holding | 269 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Cumberland Pharmaceuticals | 93 |
| BioXcel Therapeutics | 29 |
| SCYNEXIS | 18 |
| Cardiol Therapeutics | 18 |
| Talphera | 12 |
INCR News
- 5 days ago - InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - GlobeNewsWire
- 12 days ago - InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition - GlobeNewsWire
- 2 months ago - InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire
- 4 months ago - InterCure receives noncompliance notification from Nasdaq - TheFly
- 4 months ago - InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewsWire
- 4 months ago - InterCure reports preliminary FY25 revenue NIS 265M - TheFly
- 4 months ago - InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - GlobeNewsWire
- 8 months ago - InterCure, Cannasoul sign strategic investment, collaboration agreements - TheFly